Go Pro

RTW Biotech Opportunities (RTW) Competitors

RTW Biotech Opportunities logo
GBX 2.40 -0.01 (-0.41%)
As of 12:11 PM Eastern

RTW vs. SDV, RSE, CIP, PGIT, and DNE

Should you buy RTW Biotech Opportunities stock or one of its competitors? MarketBeat compares RTW Biotech Opportunities with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with RTW Biotech Opportunities include Chelverton UK Dividend Trust (SDV), Riverstone Energy (RSE), CIP Merchant Capital (CIP), Premier Global Infrastructure Trust PLC (PGIT.L) (PGIT), and Dunedin Enterprise Investment Trust (DNE). These companies are all part of the "asset management" industry.

How does RTW Biotech Opportunities compare to Chelverton UK Dividend Trust?

Chelverton UK Dividend Trust (LON:SDV) and RTW Biotech Opportunities (LON:RTW) are both small-cap financial services companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations, institutional ownership and media sentiment.

1.9% of Chelverton UK Dividend Trust shares are owned by institutional investors. Comparatively, 2.8% of RTW Biotech Opportunities shares are owned by institutional investors. 1.5% of Chelverton UK Dividend Trust shares are owned by insiders. Comparatively, 0.6% of RTW Biotech Opportunities shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Chelverton UK Dividend Trust has a beta of 0.7166866, meaning that its stock price is 28% less volatile than the broader market. Comparatively, RTW Biotech Opportunities has a beta of 0.777, meaning that its stock price is 22% less volatile than the broader market.

RTW Biotech Opportunities has higher revenue and earnings than Chelverton UK Dividend Trust. RTW Biotech Opportunities is trading at a lower price-to-earnings ratio than Chelverton UK Dividend Trust, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chelverton UK Dividend Trust£5.33M5.86£8.87M£21.906.35
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04

In the previous week, Chelverton UK Dividend Trust's average media sentiment score of 0.00 equaled RTW Biotech Opportunities'average media sentiment score.

Company Overall Sentiment
Chelverton UK Dividend Trust Neutral
RTW Biotech Opportunities Neutral

RTW Biotech Opportunities has a net margin of 158.61% compared to Chelverton UK Dividend Trust's net margin of 86.83%. RTW Biotech Opportunities' return on equity of 36.01% beat Chelverton UK Dividend Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
Chelverton UK Dividend Trust86.83% 15.15% 0.90%
RTW Biotech Opportunities 158.61%36.01%-0.47%

Summary

RTW Biotech Opportunities beats Chelverton UK Dividend Trust on 7 of the 11 factors compared between the two stocks.

How does RTW Biotech Opportunities compare to Riverstone Energy?

Riverstone Energy (LON:RSE) and RTW Biotech Opportunities (LON:RTW) are both small-cap financial services companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, earnings, risk, institutional ownership, dividends and valuation.

RTW Biotech Opportunities has higher revenue and earnings than Riverstone Energy. Riverstone Energy is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Riverstone Energy£31.65M0.89£78.63M-£2.17N/A
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04

In the previous week, Riverstone Energy's average media sentiment score of 0.00 equaled RTW Biotech Opportunities'average media sentiment score.

Company Overall Sentiment
Riverstone Energy Neutral
RTW Biotech Opportunities Neutral

Riverstone Energy has a beta of 0.127, meaning that its stock price is 87% less volatile than the broader market. Comparatively, RTW Biotech Opportunities has a beta of 0.777, meaning that its stock price is 22% less volatile than the broader market.

RTW Biotech Opportunities has a net margin of 158.61% compared to Riverstone Energy's net margin of -0.58%. RTW Biotech Opportunities' return on equity of 36.01% beat Riverstone Energy's return on equity.

Company Net Margins Return on Equity Return on Assets
Riverstone Energy-0.58% -0.20% -0.22%
RTW Biotech Opportunities 158.61%36.01%-0.47%

8.2% of Riverstone Energy shares are held by institutional investors. Comparatively, 2.8% of RTW Biotech Opportunities shares are held by institutional investors. 66.9% of Riverstone Energy shares are held by insiders. Comparatively, 0.6% of RTW Biotech Opportunities shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

RTW Biotech Opportunities beats Riverstone Energy on 7 of the 11 factors compared between the two stocks.

How does RTW Biotech Opportunities compare to CIP Merchant Capital?

RTW Biotech Opportunities (LON:RTW) and CIP Merchant Capital (LON:CIP) are both small-cap asset management industry companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, valuation, dividends, profitability, earnings, analyst recommendations and risk.

RTW Biotech Opportunities has higher revenue and earnings than CIP Merchant Capital. CIP Merchant Capital is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04
CIP Merchant Capital£8.87M0.00N/A£13.70N/A

2.8% of RTW Biotech Opportunities shares are owned by institutional investors. 0.6% of RTW Biotech Opportunities shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, RTW Biotech Opportunities' average media sentiment score of 0.00 equaled CIP Merchant Capital'saverage media sentiment score.

Company Overall Sentiment
RTW Biotech Opportunities Neutral
CIP Merchant Capital Neutral

RTW Biotech Opportunities has a net margin of 158.61% compared to CIP Merchant Capital's net margin of 0.00%. RTW Biotech Opportunities' return on equity of 36.01% beat CIP Merchant Capital's return on equity.

Company Net Margins Return on Equity Return on Assets
RTW Biotech Opportunities158.61% 36.01% -0.47%
CIP Merchant Capital N/A N/A N/A

Summary

RTW Biotech Opportunities beats CIP Merchant Capital on 6 of the 8 factors compared between the two stocks.

How does RTW Biotech Opportunities compare to Premier Global Infrastructure Trust PLC (PGIT.L)?

Premier Global Infrastructure Trust PLC (PGIT.L) (LON:PGIT) and RTW Biotech Opportunities (LON:RTW) are both small-cap asset management industry companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, media sentiment, analyst recommendations, institutional ownership, earnings and dividends.

RTW Biotech Opportunities has a net margin of 158.61% compared to Premier Global Infrastructure Trust PLC (PGIT.L)'s net margin of 0.00%. RTW Biotech Opportunities' return on equity of 36.01% beat Premier Global Infrastructure Trust PLC (PGIT.L)'s return on equity.

Company Net Margins Return on Equity Return on Assets
Premier Global Infrastructure Trust PLC (PGIT.L)N/A N/A N/A
RTW Biotech Opportunities 158.61%36.01%-0.47%

RTW Biotech Opportunities has higher revenue and earnings than Premier Global Infrastructure Trust PLC (PGIT.L). Premier Global Infrastructure Trust PLC (PGIT.L) is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Premier Global Infrastructure Trust PLC (PGIT.L)-£2.54M0.00N/A-£40.70N/A
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04

In the previous week, Premier Global Infrastructure Trust PLC (PGIT.L)'s average media sentiment score of 0.00 equaled RTW Biotech Opportunities'average media sentiment score.

2.8% of RTW Biotech Opportunities shares are held by institutional investors. 0.6% of RTW Biotech Opportunities shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

RTW Biotech Opportunities beats Premier Global Infrastructure Trust PLC (PGIT.L) on 7 of the 8 factors compared between the two stocks.

How does RTW Biotech Opportunities compare to Dunedin Enterprise Investment Trust?

RTW Biotech Opportunities (LON:RTW) and Dunedin Enterprise Investment Trust (LON:DNE) are both small-cap financial services companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, dividends and analyst recommendations.

In the previous week, RTW Biotech Opportunities' average media sentiment score of 0.00 equaled Dunedin Enterprise Investment Trust'saverage media sentiment score.

Company Overall Sentiment
RTW Biotech Opportunities Neutral
Dunedin Enterprise Investment Trust Neutral

2.8% of RTW Biotech Opportunities shares are owned by institutional investors. Comparatively, 32.6% of Dunedin Enterprise Investment Trust shares are owned by institutional investors. 0.6% of RTW Biotech Opportunities shares are owned by insiders. Comparatively, 68.6% of Dunedin Enterprise Investment Trust shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

RTW Biotech Opportunities has a net margin of 158.61% compared to Dunedin Enterprise Investment Trust's net margin of 74.24%. RTW Biotech Opportunities' return on equity of 36.01% beat Dunedin Enterprise Investment Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
RTW Biotech Opportunities158.61% 36.01% -0.47%
Dunedin Enterprise Investment Trust 74.24%3.62%2.87%

RTW Biotech Opportunities has a beta of 0.777, suggesting that its share price is 22% less volatile than the broader market. Comparatively, Dunedin Enterprise Investment Trust has a beta of 0.46, suggesting that its share price is 54% less volatile than the broader market.

RTW Biotech Opportunities has higher revenue and earnings than Dunedin Enterprise Investment Trust. Dunedin Enterprise Investment Trust is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RTW Biotech Opportunities£250.89M0.03£14.09B£63.000.04
Dunedin Enterprise Investment Trust£1.99M0.00£1.56M£28.41N/A

Summary

RTW Biotech Opportunities beats Dunedin Enterprise Investment Trust on 6 of the 10 factors compared between the two stocks.

Get RTW Biotech Opportunities News Delivered to You Automatically

Sign up to receive the latest news and ratings for RTW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RTW vs. The Competition

MetricRTW Biotech OpportunitiesAsset Management IndustryFinancial SectorLON Exchange
Market Cap£7.75M£2.54B£6.21B£2.78B
Dividend YieldN/A6.00%5.24%6.13%
P/E Ratio0.0462.8430.12368.63
Price / Sales0.031,850.861,180.4284,796.30
Price / Cash0.3260.3388.6827.87
Price / Book0.012.167.157.79
Net Income£14.09B£265.27M£1.13B£5.89B
7 Day Performance-2.04%1.86%0.96%1.32%
1 Month Performance6.67%1.56%0.74%-0.69%
1 Year Performance84.90%8.38%15.98%62.55%

RTW Biotech Opportunities Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RTW
RTW Biotech Opportunities
N/AGBX 2.40
-0.4%
N/A+92.8%£7.75M£250.89M0.044,971
SDV
Chelverton UK Dividend Trust
N/AGBX 136.60
-1.4%
N/A-4.1%£30.67M£5.33M6.24N/A
RSE
Riverstone Energy
N/AGBX 575.04
flat
N/A-30.2%£27.73M£31.65MN/AN/A
CIP
CIP Merchant Capital
N/AN/AN/AN/A£27.50M£8.87M3.65N/A
PGIT
Premier Global Infrastructure Trust PLC (PGIT.L)
N/AN/AN/AN/A£26.23M-£2.54MN/AN/A

Related Companies and Tools


This page (LON:RTW) was last updated on 7/15/2026 by MarketBeat.com Staff.
From Our Partners